Becker Private Equity & Business Podcast

1559 Folgen

1. The Future of Productivity and AI in Healthcare with Matt Wolf of RSM 9-26-24

   Vom: 26.9.2024
2. HP’s Success, Costco’s Growth, and the Impact of Trade Tariffs 9-26-24

   Vom: 26.9.2024
3. 5 Stories to Watch: Market Momentum, Powell’s Leadership, and Financial Challenges for Retirees 9-26-24

   Vom: 26.9.2024
4. NVIDIA’s Surge, Disney’s Struggles, and KKR’s Resilience: Key Market Updates 9-25-24

   Vom: 25.9.2024
5. Economic Divide, Billionaire Club, and Stock Market Surge: 6 Key Business Stories 9-25-24

   Vom: 25.9.2024
6. Consumerism in Healthcare and Private Equity Insights with Amber Walsh, Partner at McGuireWoods LLP 9-24-24

   Vom: 24.9.2024
7. The Economy: A Tale of Two Cities 9-24-24

   Vom: 24.9.2024
8. Disney Faces Slowdown in Parks Amid Rising Costs and Soft Demand 9-24-24

   Vom: 24.9.2024
9. KKR’s Remarkable Year: $4.6 Billion Fund Raised Amid Tough Market Conditions 9-24-24

   Vom: 24.9.2024
10. Private Equity Trends and Healthcare Investment Insights with Richard Kes, Partner at RSM 9-23-24

    Vom: 23.9.2024
11. The Crucial Balance Between Boards and CEOs 9-23-24

    Vom: 23.9.2024
12. 6 Quick Notes: Treasury Yields, Nike’s Rebound, and the Leadership Balancing Act 9-23-24

    Vom: 23.9.2024
13. 8 Business Stories to Watch: Market Surge, Intel’s Future, and Retail Giants 9-23-24

    Vom: 23.9.2024
14. Despair is the Failure of Imagination 9-21-24

    Vom: 21.9.2024
15. Tesla, Rivian, and Lucid Motors: The Good, the Bad, and the Ugly 9-21-24

    Vom: 21.9.2024
16. Navigating Post-Rate Cut Deal Activity: Insights from Matt Wolf of RSM 9-20-24

    Vom: 20.9.2024
17. Market Leaders: Apple, Microsoft, Walmart, and Amazon’s Year-to-Date Performance 9-20-24

    Vom: 20.9.2024
18. Insights on Co-Investment: Opportunities and Risks 9-20-24

    Vom: 20.9.2024
19. Addressing the Physician Shortage: Insights from Amber Walsh, Partner at McGuireWoods LLP 9-19-24

    Vom: 19.9.2024
20. Private Equity Giants and Big Payers: Year-to-Date Stock Performance 9-19-24

    Vom: 19.9.2024